The Semester-In-Residence (SIR) program is a unique part of the California State University San Marcos’ Professional Science Master’s in Biotechnology. The program provides students with the opportunity to work in a biotechnology or related life sciences business to address a real-world issue, project or problem by integrating new skills and information gained from their coursework.
The project functions as a capstone experience in lieu of a Master’s thesis, and runs for approximately 15 weeks requiring 300 hours of work. It is similar to a structured internship with a very specific, comprehensive schedule of deliverables established by the student, in consultation with the CSUSM Biotechnology Advisory Committee and the community partner.
Abbott Vascular | Active Motif | Ajinomoto Althea Inc. | Alere, Inc. | Althea Technologies | Ambryx, Inc. | Ardea Biosciences | Autogenomics | BioLegend Inc. | Bioresearch, Inc. | BD Biosciences | Carlsbad Aquafarm | Cliniqa Corporation | CSUSM | Dramm & Echter | Eco Feedstock | Encina Waste | Exeligen | Genentech | Genmark Diagnostics, Inc. | Genoptix | Howard Hughes Medical Institute | Ibis Biosciences, an Abbott Company | Illumina Inc. | Imgenex Corporation | Life Technologies | MaVax Therapeutics | Media. Genentech, Inc. | Millipore | Myron L Company | Neuropore Therapies, Inc | Point Loma Wastewater Treatment Plant | Promethean Biofuels Cooperative Corp. | Quidel Corporation | San Diego Zoo Global Institute for Conservation Research | San Diego Sheriffs Department, Crime Lab | Sapphire Energy | The Scripps Research Institute | Seacoast Science, Inc. | Sirigen/BDB | Syntron Bioresearch, Inc. | T2 Energy | ThermoFisher Scientific | Time Logic | Valicor Renewables | Water Authority